These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22830204)

  • 1. [Rheumatoid arthritis: problems and significance of personalized medicine].
    Ter Arkh; 2012; 84(5):5-9. PubMed ID: 22830204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcript profiling towards personalised medicine in rheumatoid arthritis.
    Verweij CL
    Neth J Med; 2009 Dec; 67(11):364-71. PubMed ID: 20009112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized medicine in rheumatoid arthritis: hopes and challenges.
    Bridges SL
    Bull NYU Hosp Jt Dis; 2007; 65(3):174-7. PubMed ID: 17922665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward personalized medicine in the neuropsychiatric field.
    Wong EH; Fox JC; Ng MY; Lee CM
    Int Rev Neurobiol; 2011; 101():329-49. PubMed ID: 22050858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of personalized medicine in the disease genomic era.
    Hong KW; Oh B
    BMB Rep; 2010 Oct; 43(10):643-8. PubMed ID: 21034525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systems biology guided by Chinese medicine reveals new markers for sub-typing rheumatoid arthritis patients.
    van Wietmarschen H; Yuan K; Lu C; Gao P; Wang J; Xiao C; Yan X; Wang M; Schroën J; Lu A; Xu G; van der Greef J
    J Clin Rheumatol; 2009 Oct; 15(7):330-7. PubMed ID: 20009967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalised treatment of arthritis in the next eRA.
    Tas SW
    Neth J Med; 2009 Dec; 67(11):362-3. PubMed ID: 20009111
    [No Abstract]   [Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dealing with the evidence dilemma in genomics and personalized medicine.
    Khoury MJ
    Clin Pharmacol Ther; 2010 Jun; 87(6):635-8. PubMed ID: 20485318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized health care: from theory to practice.
    Snyderman R
    Biotechnol J; 2012 Aug; 7(8):973-9. PubMed ID: 22180345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized medicine in oncology: tailoring the right drug to the right patient.
    Jiang Y; Wang M
    Biomark Med; 2010 Aug; 4(4):523-33. PubMed ID: 20701441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of genomics on personalized cancer medicine.
    Arteaga CL; Baselga J
    Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial pharma-Q-genomics: targeting the OXPHOS cytochrome b.
    Gómez-Durán A; Pacheu-Grau D; López-Pérez MJ; Montoya J; Ruiz-Pesini E
    Drug Discov Today; 2011 Mar; 16(5-6):176-80. PubMed ID: 21112412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infectious diseases--new horizons].
    Spirer Z; Barzilai A
    Harefuah; 2012 Aug; 151(8):483-7, 496. PubMed ID: 23350296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technology insight: gene transfer and the design of novel treatments for rheumatoid arthritis.
    Moritz F; Distler O; Ospelt C; Gay RE; Gay S
    Nat Clin Pract Rheumatol; 2006 Mar; 2(3):153-62. PubMed ID: 16932675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From genomic landscapes to personalized cancer management-is there a roadmap?
    Swanton C; Caldas C
    Ann N Y Acad Sci; 2010 Oct; 1210():34-44. PubMed ID: 20973797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How the science of personalized medicines will change the clinical management of patients in the pharmacy.
    Airley R; Evans A
    Future Med Chem; 2012 Oct; 4(16):2023-7. PubMed ID: 23157235
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacogenomics of antirheumatic drugs and personalized medicine for rheumatoid arthritis].
    Taniguchi A; Urano W; Tanaka E; Kamatani N
    Nihon Rinsho; 2007 Feb; 65(2):371-9. PubMed ID: 17302286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers and personalized therapy in chronic kidney diseases.
    Schena FP
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1051-4. PubMed ID: 24857812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A piece in the puzzle of personalized medicine.
    Kroemer HK; Meyer zu Schwabedissen HE
    Clin Pharmacol Ther; 2010 Jan; 87(1):19-20. PubMed ID: 20019696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.